In unserem Newsroom finden Sie Aktuelles rund um die German Breast Group.
GBG research at ESMO Breast Cancer Meeting 2022 May 3rd to 5th in Berlin.
ESMO has announced that the 2022 ESMO Breast Cancer Award is presented to Sibylle Loibl for her exceptional contribution to clinical research in breast cancer.
We are pleased to inform you that 4-year follow-up data from the BrighTNess trial has been published in Annals of Oncology.
„Ich habe / hatte Krebs“ Welches Bild haben Betroffene von ihrer Brustkrebserkrankung? Teilnehmer*innen für wissenschaftliche Online-Studie gesucht
Vielen Dank für Ihre Teilnahme am GBG-Jahrestreffen 2022. Sie finden die Vorträge hier zum Nachlesen auf unserer Website.
We are pleased to inform you that a meta-analysis of capecitabine effect as part of neo-/adjuvant chemotherapy including 15,993 patients from 13 randomized trials has been published in European Journal of Cancer.
Das AGO Mammakarzinom - State of the Art Meeting findet am 19. März 2022 online statt.
We are pleased to inform you that an exploratory analysis of the randomized phase III GrparOcto trial has been published in Cancer
Exploratory analysis of GeparOcto patients published in "Cancers"
Deutschlands größter digitaler Patientenkongress zu Brust- und Eierstockkrebs am 5. und 6. Februar 2022
A biomarker analysis in luminal breast cancer using a humanized tumor mouse (HTM) model has been published in International Journal of Cancer.
We are delighted to inform you that an overview of data on CDK4/6 inhibitors in the treatment of breast cancer has been published in Breast.
Erfahrungsbericht einer Betroffenen zur Diagnose und Behandlung eines Mammakarzinoms in der Frühschwangerschaft.
We are happy to present our work at the San Antonio Breast Cancer Symposium, December 7-10 2021
The survival analysis of the randomized phase III GeparOcto trial has been published in European Journal of Cancer
An analysis evaluating RAD51 test and its association with HRD and clinical outcome in primary TNBC from GeparSixto trial has been published in Annals of Oncology.
Molekulare Onkologie in der Praxis – virtuelle Weiterbildungsveranstaltung am 27. Oktober, 17:00 bis 20:00 Uhr
We are delighted to inform you that our results on the GAIN-2 trial has been published in European Journal of Cancer
We are happy to present our work at ESMO 2021, September 16-21th